Citius Oncology Files 8-K: Other Events
Ticker: CTOR · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1851484
Sentiment: neutral
Topics: 8-K, other-events, filing
TL;DR
Citius Oncology filed an 8-K for 'Other Events' - no major news yet.
AI Summary
On June 26, 2025, Citius Oncology, Inc. filed an 8-K report detailing an 'Other Events' filing. The company, formerly known as TenX Keane Acquisition until March 15, 2021, is incorporated in Delaware and has its principal executive offices in Cranford, NJ. The filing does not disclose specific financial transactions or material events beyond its classification.
Why It Matters
This 8-K filing indicates that Citius Oncology has reported an event classified under 'Other Events,' which could encompass a range of disclosures not fitting into standard 8-K categories.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any new material financial information or significant business changes.
Key Players & Entities
- CITIUS ONCOLOGY, INC. (company) — Registrant
- TenX Keane Acquisition (company) — Former Company Name
- June 26, 2025 (date) — Date of Report
- Cranford, NJ (location) — Principal Executive Offices
FAQ
What specific event is Citius Oncology reporting under 'Other Events' in this 8-K filing?
The provided text of the 8-K filing does not specify the exact nature of the 'Other Events' being reported, only that it falls under this category.
When was Citius Oncology previously known by another name?
Citius Oncology, Inc. was formerly known as TenX Keane Acquisition, with the name change occurring on March 15, 2021.
Where are Citius Oncology's principal executive offices located?
The principal executive offices of Citius Oncology, Inc. are located at 11 Commerce Drive, 1st Floor, Cranford, NJ 07016.
What is the SIC code for Citius Oncology, Inc.?
The Standard Industrial Classification (SIC) code for Citius Oncology, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing date of this 8-K report?
The 8-K report was filed as of June 27, 2025, with the earliest event reported being on June 26, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding CITIUS ONCOLOGY, INC. (CTOR).